Release Details

SOUTH PLAINFIELD, N.J., Nov. 13, 2014 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that it will hold its 2^nd Annual Science Day on Monday, November 24, 2014 from 8:00 a.m. to 12:00 p.m. ET at the Le Parker Meridien in New York City. Members of PTC's senior management and research teams will provide a corporate update and in-depth reviews of the company's scientific platforms and R&D programs.

Additionally, PTC will present a company update at the following conferences in December:

• Deutsche Bank BioFEST on Tuesday, December 2^nd at 7:30 a.m. ET at the Four Seasons Hotel in Boston
• Oppenheimer 25^th Annual Healthcare Conference on Thursday, December 11^th
  at 9:10 a.m. ET at the Crowne Plaza Hotel in New York City

The presentations will be webcast live and available on the Events and Presentations page under the Investor Relations section of PTC Therapeutics' website at www.ptcbio.com. The webcast will be archived for 30 days following the presentation. It is recommended that users connect to PTC's website several minutes prior to the start of the webcast to ensure a timely connection. PTC's current Investor Presentation slide deck and the R&D slide deck are available at the same website location.

About PTC Therapeutics, Inc.
PTC is a biopharmaceutical company focused on the discovery and development of orally administered, proprietary small molecule drugs that target post-transcriptional control processes. Post-transcriptional control processes regulate the rate and timing of protein production and are essential to proper cellular function. PTC's internally discovered pipeline addresses multiple therapeutic areas, including rare disorders, oncology and infectious diseases. PTC has developed proprietary technologies that it applies in its drug discovery activities and in collaborations with leading biopharmaceutical companies. For more information on the company, please visit our website www.ptcbio.com 

SOURCE PTC Therapeutics, Inc.